Karen Flynn Insider Trading $REPH Recro Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Karen Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Karen Flynn. Karen Flynn is President, America's Region in WEST PHARMACEUTICAL SERVICES INC ($WST) and President, Pharma Pckg Systems in WEST PHARMACEUTICAL SERVICES INC ($WST) and Sr VP & Chief Commercial Offic in WEST PHARMACEUTICAL SERVICES INC ($WST) and Director in Recro Pharma, Inc. ($REPH) and Pres. Biologics & CCO in Catalent, Inc. ($CTLT).
Karen Flynn in Recro Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen Flynn: Director
Holdings: 39,283 shares
Current Value: $316,228
Latest Transaction: Dec 16 2019
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Karen Flynn in Recro Pharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CTLT, REPH, WST
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16 2019 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Grant | A | 0.00 | 11,071 | 0 | 39,283 | 28.2 K to 39.3 K (+39.24 %) |
| May 13 2019 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Option Exercise | A | 8.80 | 10,888 | 95,814 | 10,888 | |
| May 13 2019 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Grant | A | 0.00 | 7,955 | 0 | 28,212 | 20.3 K to 28.2 K (+39.27 %) |
| May 14 2018 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Option Exercise | M | 0.00 | 13,274 | 0 | 0 | |
| May 14 2018 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Buy | M | 0.00 | 13,274 | 0 | 20,257 | 7 K to 20.3 K (+190.09 %) |
| May 08 2018 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
| May 08 2018 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Grant | A | 0.00 | 6,183 | 0 | 6,983 | 800 to 7 K (+772.88 %) |
| May 16 2017 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Option Exercise | A | 0.00 | 13,274 | 0 | 13,274 | |
| Dec 19 2016 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Buy | P | 6.71 | 800 | 5,364 | 800 | 0 to 800 |
| Dec 18 2015 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Option Exercise | A | 8.41 | 10,000 | 84,100 | 10,000 | |
| Sep 08 2015 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Option Exercise | A | 13.89 | 20,000 | 277,800 | 20,000 |
Page: 1